AKT1 and primary ovarian failure: Meanwhile, cisplatin treatment decreased PTEN levels and increased the phosphorylation and activation of key molecules in the PTEN/Akt/FOXO3 pathway causing follicular activation and resulting in premature ovarian failure [97].